SPP1 and glioblastoma: Our results support that pharmacological inhibition of FAK, which disrupts the engagement of αvβ3 integrin and osteopontin, reverses the metabolic shift decreases glycolysis, and increases mitochondrial function, and subsequently inhibits migration and growth of GBM cells.